PMGC Holdings Inc. ELAB
At closeNov 3, 2026, 7:14 PM EST
After hours · Nov 3, 7:14 PM ET
- YTD
- -99.45%
- 1 year
- -99.86%
- Market cap
- 1.57M
- Revenue (ttm)
- 2.47M
- Profit margin
- -192.08%
- EPS (ttm)
- -1,748.36
- Shares out
- 3.07M
- YTD return
- -99.45%
- 1-year return
- -99.86%
- Volume
- 225.19K
- Avg volume
- 241.10K
- Open
- 1.91
- Previous close
- 2.10
- Day's range
- 1.86 – 2.18
- 52-week range
- 1.84 – 1,471.20
2Y -23,577.04 (-99.99%)
Key statistics
- Enterprise value
- 569.06K
- PEG ratio
- 0.00
- Price / sales
- 3.24
- Price / book
- 11.81
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 91.30%
- Free cash flow
- -3.57M
- Total cash
- 100.03K
- Total debt
- 140.06K
- Return on equity
- -351.00%
- Short % of float
- 22.28%
- 50-day average
- 7.79
- 200-day average
- 77.01
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About PMGC Holdings Inc.
Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs Inc. was incorporated in 2020 and is based in Newport Beach, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- elevaiskincare.com
News
PMGC Holdings Registers A Doing-Business-As Name As Northstrive Holdings, And Enters Into A Trademark License Agreement With NorthStrive Companies
PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy PMGC Holdings’ Northstrive Biosciences Executes Statement Of Work With Charles River To Conduct Analytical Characterization Supporting Development Of EL-22 And EL-32 Engineered Probiotic Programs
NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs
PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings PMGC Holdings’ Northstrive Amends Development And License Agreement With Yuva Biosciences To Launch Three-Phase Program Advancing Four AI-Discovered Compounds And Updating AI Scope, IP, Field Of Use, And Financial Terms
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio
Your note
Sign in to keep a note on ELAB — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sabby Management, LLC | 0.00% | 12,709 | 33.17K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.00% | 226 | 589 | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.00% | 216 | 563 | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.00% | 196 | 511 | Sep 29, 2024 |
| HRT Financial LP | 0.00% | 179 | 467 | Sep 29, 2024 |
| Diversify Advisory Services, LLC | 0.00% | 125 | 326 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.00% | 226 | 589 | Oct 30, 2024 |
